Licensed Practical Nurse in Glen Burnie, MD Accepting Medicare
6 Licensed Practical Nurse nurses found. Showing 1 - 6
 Mrs. Jean Marie Preston, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7910aquahart Rd., 3rd Floor, Glen Burnie, MD 21061 Phone: 410-222-6838 Fax: 410-222-6840 |
Darlene Yvonne Dittrich, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 791 Aquahart Rd, Suite 200, Glen Burnie, MD 21061 Phone: 410-222-6625 Fax: 410-222-6679 |
Mrs. Robin Joyce Brocious, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 330 Oak Manor Dr, Glen Burnie, MD 21061 Phone: 410-222-6420 |
Dominique Sharps, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 550 North Chain Hwy, Suite 899, Glen Burnie, MD 21061 Phone: 443-517-6552 Fax: 410-946-1752 |
Amber Sue Bruchalski, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Rosedale Ave, Glen Burnie, MD 21061 Phone: 410-768-4291 |
Mercy Lar, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7995 Nolpark Ct, # 102, Glen Burnie, MD 21061 Phone: 410-969-6374 |
News Archive
DecImmune and DSM to develop proprietary antibody therapeutic
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA.
Technology used on the ISS could reveal important information about human health
In an article published recently in Microgravity, a Nature Journal, researchers at Rensselaer Polytechnic Institute demonstrate a unique method for studying the mechanisms behind the formation of amyloid fibrils associated with diseases like Alzheimer's and Parkinson's.
nSpire Health sales increase 3% to $27.6M for 2011
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
FDA approves Actavis' generic Suboxone ANDA to treat opioid dependence
Actavis, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone.
› Verified 7 days ago